|
Licensing Opportunities
The following technologies are available for licence as detailed below.
|
|
|
| Product |
Indication |
Licenses Available |
LAIV cell based manufacturing method
|
Influenza |
Europe
US
Japan
Other countries except Russia and CIS.
|
LAIV egg based manufacturing method
|
Influenza |
Europe (excluding Russia & CIS)
Japan
USA
|
| LAIV viral vector |
Platform technology - multiple applications |
Co-development licences
Commercialisation licences (GMP LAIV material and cell line available)
|
| BDM-E |
Retinitis Pigmentosa & other retinal diseases
|
Worldwide rights for co-development or out-licence (except Russia & CIS)
|
| BDM-I |
Antimicrobial
|
Wordwide rights for co-development
|
Non-confidential summaries of each licensing opportunity are available upon request from the Company.
Contact
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
This e-mail address is protected from spambots. You need JavaScript enabled to view it.
|
